Active substances

Azelastine.

Indications

Tebarat 0.5 mg/ml eye drops is indicated for the treatment and prevention of allergic conjunctivitis.
Treatment and prevention of seasonal allergic conjunctivitis symptoms in adults and children aged 4 years and over.
Treatment of non-seasonal (perennial) allergic conjunctivitis symptoms in adults and children aged 12 years and over.

Presentation

Box with 30 single doses.

Posology

Seasonal allergic conjunctivitis: the usual dose in adults and children aged 4 years and over is one drop in each eye twice a day, which can be increased if necessary to four times a day. If exposure to the allergen is expected, Tebarat® should be administered as prophylaxis before said exposure.
Non-seasonal (perennial) allergic conjunctivitis: the usual dose in adults and children aged 12 years and over is one drop in each eye twice a day, which can be increased if necessary to four times a day. As safety and efficacy have been demonstrated in clinical trials for a 6-week period, the duration of treatment should be limited to a maximum of 6 weeks.

Summary of Product Characteristics (external link to the Spanish Drug Agency)

Esta web usa 'cookies' propias y de terceros para ofrecerte una mejor experiencia de servicio. Al navegar o utilizar nuestros servicios, aceptas el uso que hacemos de las 'cookies'. Sim embargo, puedes cambiar la configuración de 'cookies' en cualquier momento.

VER MÁS

This web uses cookies (including some third party) to facilitate the use of our website. By browsing this web or using its services, you are accepting how we use these cookies. However, you may change the cookie configuration at any time.

READ MORE